ZfP Südwürttemberg
- Address
- Weingartshofer Straße 2, 88214 Ravensburg, Germany
ZfP Südwürttemberg - Neurological Research Center
ZfP Südwürttemberg is a specialized neurological research center with expertise in evaluating innovative therapeutic approaches for complex neurological conditions. The center focuses on advancing treatment options for patients with challenging neurological disorders, particularly those who have not responded adequately to standard therapies.
- Refractory epilepsy and seizure disorders
- Novel antiepileptic drug development and evaluation
- Adjunctive therapy optimization for focal onset epilepsy
The center specializes in clinical trials investigating refractory focal onset epilepsy, conducting rigorous efficacy and safety assessments of investigational medications for patients who continue to experience seizures despite conventional treatment. Their research contributes to expanding therapeutic options for individuals living with treatment-resistant epilepsy, utilizing advanced methodologies to measure seizure reduction and evaluate long-term outcomes in this challenging patient population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Biohaven Therapeutics Ltd.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Biohaven Therapeutics Ltd.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ZfP Südwürttemberg
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of BHV-7000 in Adults with Refractory Focal Onset Epilepsy: A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study | Biohaven Therapeutics Ltd. | Phase IV | Not Recruiting | Sep 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bhv-7000 | 3 | Unknown | 2024-09-25 | 2024-12-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.